Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/e4d578b3-8a6d-4687-a221-589ba6630126/

SLBT

SL Science Holding Limited Ordinary Shares
Chart
4.30 USD
Latest Week 2026-07-17
Snapshot 2026-07-19 · 0.6w · Fresh
0.38
OS Score
44.0%
Value
42.0%
Quality
43.0%
Momentum
3/9
F-Score
0.430
QV
Strategy Eligibility
0 of 23 passing
OS Composite
Trending Value
Quality × Value
🏛
Cornerstone Value
🌿
Cornerstone Growth
💎
Deep Value
VC2 Cheapest
📐
EBITDA/EV
Veiled Value
Piotroski Bargains
🔬
Quality Compounders
📈
Consistent Earners
🌱
GARP
🔄
Shareholder Yield
💰
High Yield
🚀
Momentum Leaders
Market Leaders
Tiny Titans
🔍
Small Cap Value
🛡
Low Volatility
🏷
Sector Cheapest
🧠
Capital Allocators
Risk-Adj Momentum
V
Value Analysis
Cheapness relative to fundamentals
44.0%ile
P/S
1097.4×
P/B
1055.8×
FCF Yield
-0.001
SH Yield
0.000
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
57.00000000
/100 — 1=cheapest
VC2 (Trending Value)
57.00000000
/100
VC3 (Buyback)
58.00000000
/100
Negative FCF yield (-0.1%) — the business is currently cash-consumptive.
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
42.0%ile
ROE
-1.672
ROA
-1.356
Net Margin
-1.738
Op Margin
-1.746
GPA
0.275
D/E
0.23
Current
3.05
F-Score
3/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Rev Growth
-0.347
Accruals
-0.678
lower=better
5yr Consist
No
Conservative balance sheet with D/E of 0.23.
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
43.0%ile
Max DD 12M
-35.2%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
OS
Composite & Factor Heatmap
All factors at a glance
0.38
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
Sector Context
Healthcare · 500 peers
Sector Value %ile
11.8%
Sector Quality %ile
7.6%
P/B z-score
51.43
Sector Avg OS
64.1%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
SymbolNameOSValueQualityMomentum
FBIOP Fortress Biotech Inc Pref Series A 99.0% 98.0% 84.0% 96.0%
IRWD Ironwood Pharmaceuticals Inc 99.0% 92.0% 91.0% 98.0%
CGEN Compugen 98.0% 89.0% 96.0% 82.0%
RIGL Rigel Pharmaceuticals Inc 98.0% 90.0% 93.0% 93.0%
FBIO Fortress Biotech Inc 98.0% 98.0% 84.0% 88.0%
NUTX Nutex Health Inc 98.0% 91.0% 98.0% 80.0%
TBPH Theravance Biopharma Inc 98.0% 90.0% 99.0% 84.0%
MD Mednax Inc 97.0% 85.0% 84.0% 93.0%
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
F
6.2% avg (4 factors)
Quality
D
43.6% avg (8 factors)
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Score Trends5 snapshots
Factor Persistence5 snapshots
FactorCurrentStreakTrendSpark
OS Composite0.380—0
Value %ile0.440—0
Quality %ile0.420—0
Momentum %ile0.430—0
F-Score3.000—5
Confidence0.527—0
Volatility—0
Value Lens2021-07-20 → 2026-07-19
P/E Ratio
Earnings Yield
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
Price / Sales
1097.40
Price / Book
1055.77
FCF Yield
-0.1%
Sales Yield (1/P·S)
0.0009
Shareholder Yield
Div + net buyback / mktcap
0.0%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
-167.2%
Return on Assets
-135.6%
Net Margin
-173.8%
Operating Margin
-174.6%
Gross Profit / Assets
Novy-Marx GPA
27.5%
Debt / Equity
0.23
Current Ratio
3.05
Accruals Ratio
(NI-OCF)/Assets — lower=better
-0.678
MomentumPrice trend strength over different horizons
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Revenue Growth (YoY)
-34.7%
5yr Consistent
EPS up every year for 5 years
No
Piotroski F-Score
3
Buyback Yield
0.0%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
57
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
57
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
58
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity